Laura Lisk

Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis

Mary Anne Dooley, David Jayne, Ellen M. Ginzler et al. · New England Journal of Medicine · 2011 · 636 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +15

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler et al. · The Lancet · 2021 · 593 citations

Medicine, Immunology, Nephrology +10

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

Jürgen Floege, Adrian Covic, Markus Ketteler et al. · Kidney International · 2014 · 187 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: Findings in a multicenter, prospective, randomized, open‐label, parallel‐group clinical trial

Ellen M. Ginzler, David Wofsy, David Isenberg et al. · Arthritis & Rheumatism · 2009 · 159 citations

Medicine, Pharmacology, Pharmacotherapy +11

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

Jürgen Floege, Adrian Covic, Markus Ketteler et al. · Nephrology Dialysis Transplantation · 2015 · 142 citations · Full text

Medicine, Nephrology, Pharmacotherapy +16